Descemet Endothelial Thickness Comparison Trial II
Status:
Not yet recruiting
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome
assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs
endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.
Phase:
Phase 3
Details
Lead Sponsor:
Stanford University
Collaborators:
Case Western Reserve University Kaiser Permanente Oregon Health and Science University University of California, Davis University of California, San Francisco University of Maryland, Baltimore